Immediate Impact
53 standout
Citing Papers
AXL signaling in cancer: from molecular insights to targeted therapies
2025 Standout
Tissue macrophages: origin, heterogenity, biological functions, diseases and therapeutic targets
2025 Standout
Works of Yeong‐In Yang being referenced
Abstract 2255: Patient pharmacodynamic biomarker and pk evaluation results from an ongoing phase I dose-escalation study of q702, an axl, mer and csf1r kinase inhibitor in patients with advanced solid tumors
2023
Abstract 4139: Q702, selective Axl, Mer and CSF1R triple kinase inhibitor with dual potentials leading to tumor regression: Immuno-oncology therapy and targeted cancer therapy
2019
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Yeong‐In Yang | 94 | 178 | 76 | 238 | 18 | 585 | |
| Tz‐Chong Chou | 49 | 142 | 27 | 224 | 20 | 596 | |
| Xia Han | 42 | 59 | 30 | 358 | 28 | 708 | |
| Hsien-Yeh Hsu | 68 | 221 | 60 | 245 | 14 | 724 | |
| Chao‐Neng Tseng | 34 | 75 | 50 | 380 | 29 | 672 | |
| Tracy Barnett | 45 | 322 | 14 | 172 | 11 | 614 | |
| Jing Li | 51 | 60 | 64 | 253 | 32 | 659 | |
| Dong Hyun Kim | 41 | 61 | 25 | 322 | 31 | 711 | |
| Soo-Woong Lee | 223 | 142 | 49 | 255 | 24 | 727 | |
| Eun‐Sook Yoo | 102 | 191 | 43 | 166 | 21 | 554 | |
| Ho-Jeong Na | 175 | 72 | 115 | 235 | 31 | 686 |
All Works
Loading papers...